Largest health care companies in the United States by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
UnitedHealth Group leads the 94 health care companies in the United States ranked by total debt, at CHF 65.2B, ahead of AbbVie (CHF 56.7B) and Pfizer (CHF 54.4B). Figures as of 21 Nov 2026, 05:05 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 94
- First
- UnitedHealth GroupCHF 65.2B
- Median
- CHF 2.1B
- Combined market value
- CHF 6.13T
- Countries
- 1
- Not ranked
- 46no total debt on file
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | UnitedHealth GroupUNH · Health Care | CHF 65.2B | CHF 255.7B | CHF 285.32 | 2.84% up | 3% up | ||
| 2 | AbbVieABBV · Health Care | CHF 56.7B | CHF 424.7B | CHF 240.28 | 0.94% up | 20% up | ||
| 3 | PfizerPFE · Health Care | CHF 54.4B | CHF 131.1B | CHF 23.00 | 0.51% down | 10% up | ||
| 4 | CVS HealthCVS · Health Care | CHF 54.2B | CHF 86.8B | CHF 67.87 | 1.00% up | 3% up | ||
| 5 | AmgenAMGN · Health Care | CHF 45.8B | CHF 197.8B | CHF 365.74 | 0.15% down | 30% up | ||
| 6 | Merck & CoMRK · Health Care | CHF 41.4B | CHF 276.8B | CHF 112.26 | 0.69% up | 36% up | ||
| 7 | Johnson & JohnsonJNJ · Health Care | CHF 40.2B | CHF 546.6B | CHF 227.07 | 1.25% up | 31% up | ||
| 8 | HCA HealthcareHCA · Health Care | CHF 39B | CHF 83.4B | CHF 399.26 | 3.31% up | 6% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | CHF 37.9B | CHF 100.9B | CHF 49.37 | 0.79% up | 26% up | ||
| 10 | Eli LillyLLY · Health Care | CHF 35.7B | CHF 1.01T | CHF 1,130.97 | 0.30% down | 28% up | ||
| 11 | Thermo Fisher ScientificTMO · Health Care | CHF 33.1B | CHF 208.3B | CHF 562.11 | 2.79% down | 17% up | ||
| 12 | Elevance HealthELV · Health Care | CHF 26.9B | CHF 71.6B | CHF 331.19 | 1.11% up | 21% up | ||
| 13 | Cigna GroupCI · Health Care | CHF 26.4B | CHF 59.9B | CHF 227.43 | 0.78% down | 2% down | ||
| 14 | Gilead SciencesGILD · Health Care | CHF 20.9B | CHF 173.3B | CHF 139.73 | 0.06% down | 31% up | ||
| 15 | Becton, DickinsonBDX · Health Care | CHF 16.1B | CHF 48.7B | CHF 178.64 | 0.05% up | 40% up | ||
| 16 | DanaherDHR · Health Care | CHF 15.5B | CHF 130.2B | CHF 185.00 | 3.16% down | 0% up | ||
| 17 | CenteneCNC · Health Care | CHF 14.7B | CHF 26.5B | CHF 53.55 | 2.74% down | 80% up | ||
| 18 | StrykerSYK · Health Care | CHF 13.3B | CHF 99.1B | CHF 260.26 | 0.98% down | 15% down | ||
| 19 | IQVIA HoldingsIQV · Health Care | CHF 13.2B | CHF 34B | CHF 206.38 | 1.89% down | 11% up | ||
| 20 | ViatrisVTRS · Health Care | CHF 12.1B | CHF 18.9B | CHF 16.48 | 1.26% down | 90% up | ||
| 21 | Tenet HealthcareTHC · Health Care | CHF 11.1B | CHF 17.6B | CHF 220.96 | 0.15% down | 37% up | ||
| 22 | Abbott LaboratoriesABT · Health Care | CHF 10.9B | CHF 149.8B | CHF 86.47 | 0.84% down | 19% down | ||
| 23 | MedlineMDLN · Health Care | CHF 10.5B | CHF 40.9B | CHF 31.10 | 2.11% down | 8% down | ||
| 24 | HumanaHUM · Health Care | CHF 10.4B | CHF 39.3B | CHF 327.42 | 2.63% up | 67% up | ||
| 25 | Boston ScientificBSX · Health Care | CHF 9.6B | CHF 51.1B | CHF 35.24 | 2.35% down | 56% down | ||
| 26 | GE HealthCare TechnologiesGEHC · Health Care | CHF 8.8B | CHF 30.6B | CHF 67.70 | 1.53% down | 7% up | ||
| 27 | DaVitaDVA · Health Care | CHF 8.6B | CHF 8.5B | CHF 135.19 | 3.00% up | 30% up | ||
| 28 | Baxter InternationalBAX · Health Care | CHF 8B | CHF 11B | CHF 21.32 | 0.00% | 39% up | ||
| 29 | ZoetisZTS · Health Care | CHF 7.6B | CHF 27B | CHF 66.42 | 2.08% down | 34% down | ||
| 30 | Royalty PharmaRPRX · Health Care | CHF 7.5B | CHF 33B | CHF 57.47 | 1.08% up | 74% up | ||
| 31 | Cardinal HealthCAH · Health Care | CHF 7.5B | CHF 52.9B | CHF 229.04 | 0.17% up | 30% up | ||
| 32 | CencoraCOR · Health Care | CHF 6.4B | CHF 54.3B | CHF 284.68 | 0.63% down | 7% down | ||
| 33 | Zimmer Biomet HoldingsZBH · Health Care | CHF 6.3B | CHF 16.1B | CHF 84.88 | 0.36% down | 10% up | ||
| 34 | McKessonMCK · Health Care | CHF 5.5B | CHF 103.7B | CHF 897.84 | 0.68% up | 23% up | ||
| 35 | BiogenBIIB · Health Care | CHF 5.3B | CHF 31B | CHF 209.54 | 1.00% up | 41% up | ||
| 36 | Quest DiagnosticsDGX · Health Care | CHF 4.8B | CHF 23.9B | CHF 216.84 | 0.31% down | 35% up | ||
| 37 | Labcorp HoldingsLH · Health Care | CHF 4.7B | CHF 25B | CHF 308.22 | 0.47% down | 39% up | ||
| 38 | SolventumSOLV · Health Care | CHF 4.2B | CHF 12.1B | CHF 70.94 | 1.52% down | 3% up | ||
| 39 | Universal Health ServicesUHS · Health Care | CHF 4B | CHF 8.7B | CHF 150.64 | 2.54% up | 25% down | ||
| 40 | Elanco Animal HealthELAN · Health Care | CHF 3.4B | CHF 10.8B | CHF 21.61 | 2.09% down | 18% up | ||
| 41 | AvantorAVTR · Health Care | CHF 3.3B | CHF 8.4B | CHF 12.46 | 1.85% down | 31% up | ||
| 42 | Molina HealthcareMOH · Health Care | CHF 3.2B | CHF 8.7B | CHF 166.56 | 2.43% down | 44% up | ||
| 43 | Agilent TechnologiesA · Health Care | CHF 2.8B | CHF 40.3B | CHF 143.04 | 2.83% down | 16% up | ||
| 44 | RevvityRVTY · Health Care | CHF 2.7B | CHF 13.6B | CHF 121.92 | 4.20% down | 54% up | ||
| 45 | Henry ScheinHSIC · Health Care | CHF 2.6B | CHF 7.8B | CHF 70.12 | 1.51% down | 16% up | ||
| 46 | TeleflexTFX · Health Care | CHF 2.2B | CHF 5.4B | CHF 135.65 | 1.11% down | 48% up | ||
| 47 | Amneal PharmaceuticalsAMRX · Health Care | CHF 2.2B | CHF 6.2B | CHF 17.73 | 1.26% down | 79% up | ||
| 48 | BrightSpring Health ServicesBTSG · Health Care | CHF 2.1B | CHF 10.5B | CHF 52.80 | 1.77% down | 85% up | ||
| 49 | Cooper CompaniesCOO · Health Care | CHF 2.1B | CHF 9.4B | CHF 49.43 | 2.40% down | 20% down | ||
| 50 | Encompass HealthEHC · Health Care | CHF 2.1B | CHF 11B | CHF 112.21 | 1.04% up | 16% up | ||
| 51 | Mettler-Toledo InternationalMTD · Health Care | CHF 1.8B | CHF 27.8B | CHF 1,399.43 | 2.27% down | 17% up | ||
| 52 | Halozyme TherapeuticsHALO · Health Care | CHF 1.8B | CHF 8.7B | CHF 76.69 | 1.82% down | 32% up | ||
| 53 | Charles River Laboratories InternationalCRL · Health Care | CHF 1.8B | CHF 12.6B | CHF 263.89 | 4.15% down | 96% up | ||
| 54 | BridgeBio PharmaBBIO · Health Care | CHF 1.7B | CHF 12.4B | CHF 63.83 | 2.75% down | 15% up | ||
| 55 | Regeneron PharmaceuticalsREGN · Health Care | CHF 1.7B | CHF 80B | CHF 772.97 | 0.19% down | 22% up | ||
| 56 | BrukerBRKR · Health Care | CHF 1.6B | CHF 7.2B | CHF 47.40 | 9.08% down | 31% up | ||
| 57 | Ionis PharmaceuticalsIONS · Health Care | CHF 1.5B | CHF 3.7B | CHF 22.32 | 2.35% down | 64% down | ||
| 58 | Concentra Group Holdings ParentCON · Health Care | CHF 1.3B | CHF 4.4B | CHF 35.13 | 0.94% up | 105% up | ||
| 59 | Guardant HealthGH · Health Care | CHF 1.3B | CHF 16.6B | CHF 122.43 | 0.16% up | 38% up | ||
| 60 | WatersWAT · Health Care | CHF 1.2B | CHF 72.7B | CHF 369.78 | 3.51% down | 16% up | ||
| 61 | HaemoneticsHAE · Health Care | CHF 1B | CHF 4.6B | CHF 100.88 | 0.17% down | 53% up | ||
| 62 | Bio-Rad LaboratoriesBIO · Health Care | CHF 1B | CHF 8.1B | CHF 301.31 | 2.34% down | 16% up | ||
| 63 | Option Care HealthOPCH · Health Care | CHF 974.6M | CHF 4B | CHF 26.52 | 0.06% down | 7% up | ||
| 64 | RadNetRDNT · Health Care | CHF 915M | CHF 4.6B | CHF 58.53 | 0.29% up | 16% down | ||
| 65 | HealthEquityHQY · Health Care | CHF 803.8M | CHF 6.6B | CHF 79.55 | 2.70% down | 4% down | ||
| 66 | InsuletPODD · Health Care | CHF 796.9M | CHF 7.8B | CHF 111.80 | 2.96% down | 59% down | ||
| 67 | Merit Medical SystemsMMSI · Health Care | CHF 616.3M | CHF 4.2B | CHF 70.81 | 0.08% down | 3% down | ||
| 68 | ResMedRMD · Health Care | CHF 553.6M | CHF 27.8B | CHF 197.82 | 0.53% down | 6% down | ||
| 69 | Edwards LifesciencesEW · Health Care | CHF 502.3M | CHF 49.2B | CHF 85.51 | 1.95% down | 22% up | ||
| 70 | ModernaMRNA · Health Care | CHF 495.3M | CHF 66.2B | CHF 163.71 | 2.17% down | 740% up | ||
| 71 | MSA SafetyMSA · Health Care | CHF 487.7M | CHF 5.5B | CHF 142.75 | 3.52% down | 13% up | ||
| 72 | Lantheus HoldingsLNTH · Health Care | CHF 478.1M | CHF 5.6B | CHF 85.72 | 0.00% | 83% up | ||
| 73 | InsmedINSM · Health Care | CHF 459M | CHF 26B | CHF 118.65 | 2.17% down | 27% down | ||
| 74 | RepligenRGEN · Health Care | CHF 455.2M | CHF 8.8B | CHF 137.53 | 3.81% down | 5% up | ||
| 75 | IDEXX LaboratoriesIDXX · Health Care | CHF 377.8M | CHF 44.7B | CHF 567.71 | 1.95% down | 5% down | ||
| 76 | Oscar HealthOSCR · Health Care | CHF 361.1M | CHF 6.5B | CHF 20.76 | 5.50% down | 94% up | ||
| 77 | Caris Life SciencesCAI · Health Care | CHF 318.2M | CHF 4.2B | CHF 14.76 | 5.18% down | 23% down | ||
| 78 | PACS GroupPACS · Health Care | CHF 296.5M | CHF 5.8B | CHF 36.66 | 1.49% up | 56% up | ||
| 79 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 285.3M | CHF 7.4B | CHF 318.27 | 4.45% down | 28% down | ||
| 80 | Legend BiotechLEGN · Health Care | CHF 267.9M | CHF 2.5B | CHF 12.80 | 5.28% down | 43% down | ||
| 81 | CytokineticsCYTK · Health Care | CHF 241.4M | CHF 5.9B | CHF 42.63 | 1.32% down | 21% down | ||
| 82 | LifeStance Health GroupLFST · Health Care | CHF 237.4M | CHF 4.4B | CHF 11.60 | 3.60% up | 107% up | ||
| 83 | TG TherapeuticsTGTX · Health Care | CHF 206.2M | CHF 8B | CHF 53.18 | 2.37% down | 103% up | ||
| 84 | Cogent BiosciencesCOGT · Health Care | CHF 187.1M | CHF 3.9B | CHF 22.43 | 3.70% down | 25% down | ||
| 85 | West Pharmaceutical ServicesWST · Health Care | CHF 170.3M | CHF 22.8B | CHF 327.68 | 1.61% down | 46% up | ||
| 86 | Bio-TechneTECH · Health Care | CHF 167.9M | CHF 9.6B | CHF 61.01 | 0.04% down | 18% up | ||
| 87 | Axsome TherapeuticsAXSM · Health Care | CHF 157.6M | CHF 5.7B | CHF 108.60 | 4.66% down | 9% down | ||
| 88 | Ensign GroupENSG · Health Care | CHF 121.2M | CHF 8.6B | CHF 148.03 | 0.15% down | 5% down | ||
| 89 | Adaptive BiotechnologiesADPT · Health Care | CHF 110.2M | CHF 3.8B | CHF 23.45 | 0.43% down | 51% up | ||
| 90 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 90.8M | CHF 6.5B | CHF 94.33 | 3.80% down | 15% up | ||
| 91 | Scholar Rock HoldingSRRK · Health Care | CHF 83.7M | CHF 4.9B | CHF 40.41 | 4.45% down | 25% up | ||
| 92 | BillionToOneBLLN · Health Care | CHF 48M | CHF 3.6B | CHF 75.49 | 0.31% down | 18% down | ||
| 93 | Definium TherapeuticsDFTX · Health Care | CHF 34.1M | CHF 3.3B | CHF 23.79 | 3.87% down | 176% up | ||
| 94 | CG OncologyCGON · Health Care | CHF 2.5M | CHF 6B | CHF 66.72 | 2.97% down | 93% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-21); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8396 CHF). 46 companies have no total debt on file and are not ranked here.
Questions and answers
Which health care companies in the United States rank first by total debt?
UnitedHealth Group (CHF 65.2B), AbbVie (CHF 56.7B) and Pfizer (CHF 54.4B) are the top three of the 94 health care companies in the United States ranked by total debt as of 21 Nov 2026, 05:05 UTC.
How many health care companies in the United States are in this ranking?
94 are ranked by total debt. 46 more have no total debt on file and are left out rather than ranked at zero.
What are these health care companies in the United States worth together?
The 94 health care companies in the United States ranked by total debt have a combined market value of CHF 6.13T as of 21 Nov 2026, 05:05 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies in the United States by total debt”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.